Abstract
In the review the evolution of pharmacotherapy of obesity is described, beginning with gerbal preparations, thyroid hormones and sympathomimetics and ending serotonergic agents, lipase inhibitors, peptide analogs and combined drugs. Approved drugs for the treatment of obesity, such as orlistat, lorcaserine, liraglutide, and combinations of phentermine/topiramat and naltrexone/bupropion are presented. Concluded that the most perspective drugs for the treatment of obesity in the future will be combinations of preparations with different mechanisms of action.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
